4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-006511
Options or other derivatives
- Chief Scientific Officer acquired 570,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brake Rachael Louise · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-01 | Grant or award : show line 1 in the form Stock Option (right to buy) | +570,800 | 570,800 | D |
Loading xslF345X03/doc4.xml…